Novel Concepts Medical Is Extremely Proud to Report a Big Breakthrough

A novel, plant-based, patent pending cure for Alzheimer’s disease has demonstrated efficacy in all preliminary volunteers with early to severe dementia without any side effects

This video shows the first severe Alzheimer’s disease patient, who is talking with his daughter after two years of silence and ten years of this disease. 
For more videos and details, see here.
To support our Alzheimer’s disease cure approval and distribution, please click here.

WE CAN STOP THE PANDEMIC !

TEL AVIV, Israel — The startup company Novel Concepts Medical is delighted to announce another major breakthrough in its research of COVID-19.

Its novel plant-based treatment has resulted in successfully inhibiting the COVID-19 Omicron variant and blocking its connection to human cells.

Earlier testing demonstrated:

  • Stopping the COVID-19 virus’s entry to the cells and stopping its progress 
  • In case studies, volunteers had negative PCR results within 48 hours and quickly recovered from more than 16 symptoms of long COVID-19

“Our cure can STOP Omicron, the COVID-19 virus, and Long COVID-19 symptoms. We can help reduce the high numbers of people catching COVID-19 every week. We can also help provide emergency assistance to those countries that have low vaccination rates. Our plant-based cure is safe and without any known side effects,” said founder and inventor, Dr. Rachel Alkalay.

Our company is welcoming emergency testing requests from all countries around the world, rich or poor. The novel medicine can be stored at room temperature and is made from safe and already approved compounds. We are delighted it is also eco-friendly.

Novel Concepts Medical has worked with two labs on its research. The first is the Centre for Microbial Chemical Biology at the Michael G. DeGroot Institute for Infectious Disease Research at McMaster University in Ontario, Canada. This lab is led by Dr. Tracey Campbell, who earned her PhD Biochemistry and Biomedical Sciences from McMaster University and was a Postdoctoral Fellow at Princeton University. More information about the lab can be found here: https://iidr.mcmaster.ca/cmcb/. The second lab is the Smart Assays Lab in the Weizmann Science Park in Israel. This lab is led by Dr. Raphael Mayer, who earned his PhD in Biological Chemistry from The Hebrew University of Jerusalem and was a Postdoctoral Fellow at The Rockefeller University. More information about the lab can be found here: https://www.assays.co.il/.